Indi Molecular
Biotechnology Research
Culver City, California, United States
2 employees
- Employees
- 2
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Indi Molecular Overview
- Headquarters
- Culver City, California, United States
- Website
- indimolecular.com
- Industry
- Biotechnology Research
- Employees
- 2
- Founded
- 2013
- Funding
- 11.5M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Indi Molecular
Indi Molecular is developing protein catalyzed capture (PCC) agents as a small synthetic molecule replacement for antibody-based therapeutics. PCCs are poised to play a central role in therapy given their ability to be deployed as both a precision in vivo PET diagnostic and as a targeted therapeutic. For radiotherapy this dual role is accomplished by choice of the complexed radionuclide sharing the same chelation chemistry. Chemotherapy can similarly be specifically delivered to diseased cells by the protein catalyzed capture technology. The company launched in 2013 with a $1.8 million seed round, followed by an $11.5 million Series A in 2017.
Indi Molecular Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
- Phone contacts
- 1
- 100.0% coverage
Indi Molecular Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Albert Luderer | CEO at Indi Molecular, Inc. | Greater Boston, United States |
Email
Phone
|
Compare Similar Companies to Indi Molecular
Regeneron
Biotechnology
PreciseMDX
Software Development
LadRx Corporation
Biotechnology Research
MAX BioPharma, Inc.
Biotechnology Research
Kairos Pharma
Pharmaceutical Manufacturing
Dalton Bioanalytics
Biotechnology Research
MicrobeDx
Biotechnology Research
Apollo Biologics
Biotechnology Research
Avenzoar Pharmaceuticals, Inc.
Multi-signal peer
Atengen, Inc.
Biotechnology Research